153 related articles for article (PubMed ID: 32480311)
21. Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling.
Romick-Rosendale LE; Hoskins EE; Privette Vinnedge LM; Foglesong GD; Brusadelli MG; Potter SS; Komurov K; Brugmann SA; Lambert PF; Kimple RJ; Virts EL; Hanenberg H; Gillison ML; Wells SI
Clin Cancer Res; 2016 Apr; 22(8):2062-73. PubMed ID: 26603260
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
Wreesmann VB; Estilo C; Eisele DW; Singh B; Wang SJ
ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):218-25. PubMed ID: 17409780
[TBL] [Abstract][Full Text] [Related]
23. Chromosome fragility in the buccal epithelium in patients with Fanconi anemia.
Ramírez MJ; Minguillón J; Loveless S; Lake K; Carrasco E; Stjepanovic N; Balmaña J; Català A; Mehta PA; Surrallés J
Cancer Lett; 2020 Mar; 472():1-7. PubMed ID: 31830560
[TBL] [Abstract][Full Text] [Related]
24. Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
Amenábar JM; Torres-Pereira CC; Tang KD; Punyadeera C
Cancer; 2019 Nov; 125(22):3936-3946. PubMed ID: 31390058
[TBL] [Abstract][Full Text] [Related]
25. Why otolaryngologists need to be aware of Fanconi anemia.
Lin J; Kutler DI
Otolaryngol Clin North Am; 2013 Aug; 46(4):567-77. PubMed ID: 23910470
[TBL] [Abstract][Full Text] [Related]
26. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
[TBL] [Abstract][Full Text] [Related]
27. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo inhibition of human Fanconi anemia head and neck squamous carcinoma by a phytonutrient combination.
Roomi MW; Kalinovsky T; Roomi NW; Niedzwiecki A; Rath M
Int J Oncol; 2015 May; 46(5):2261-6. PubMed ID: 25695860
[TBL] [Abstract][Full Text] [Related]
29. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
Boisvert RA; Howlett NG
Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive molecular screening for oral precancer in Fanconi anemia patients.
Smetsers SE; Velleuer E; Dietrich R; Wu T; Brink A; Buijze M; Deeg DJ; Soulier J; Leemans CR; Braakhuis BJ; Brakenhoff RH
Cancer Prev Res (Phila); 2015 Nov; 8(11):1102-11. PubMed ID: 26276748
[TBL] [Abstract][Full Text] [Related]
31. Fanconi anaemia: A syndrome with distinct subgroups.
Alter BP; Giri N; McReynolds LJ; Altintas B
Br J Haematol; 2022 May; 197(4):467-474. PubMed ID: 35191533
[TBL] [Abstract][Full Text] [Related]
32. A Case of Hypopharyngeal Cancer Associated With Fanconi Anemia: A Helical Tomotherapy Experience.
Kavak G; Basci S; Türker Kekilli E; Dal MS; Karakaya E
Cureus; 2021 Nov; 13(11):e19386. PubMed ID: 34925988
[TBL] [Abstract][Full Text] [Related]
33. Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects
Verhagen CVM; Vossen DM; Borgmann K; Hageman F; Grénman R; Verwijs-Janssen M; Mout L; Kluin RJC; Nieuwland M; Severson TM; Velds A; Kerkhoven R; O'Connor MJ; van der Heijden M; van Velthuysen ML; Verheij M; Wreesmann VB; Wessels LFA; van den Brekel MWM; Vens C
Oncotarget; 2018 Apr; 9(26):18198-18213. PubMed ID: 29719599
[TBL] [Abstract][Full Text] [Related]
34. Fanconi anemia: causes and consequences of genetic instability.
Kalb R; Neveling K; Nanda I; Schindler D; Hoehn H
Genome Dyn; 2006; 1():218-242. PubMed ID: 18724063
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of Fanconi anemia by diepoxybutane analysis.
Auerbach AD
Curr Protoc Hum Genet; 2015 Apr; 85():8.7.1-8.7.17. PubMed ID: 25827349
[TBL] [Abstract][Full Text] [Related]
36. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics.
Bogliolo M; Surrallés J
Curr Opin Genet Dev; 2015 Aug; 33():32-40. PubMed ID: 26254775
[TBL] [Abstract][Full Text] [Related]
37. Fanconi anemia pathway as a prospective target for cancer intervention.
Liu W; Palovcak A; Li F; Zafar A; Yuan F; Zhang Y
Cell Biosci; 2020; 10():39. PubMed ID: 32190289
[TBL] [Abstract][Full Text] [Related]
38. Oropharyngeal carcinoma in fanconi anemia patient - Radiation treatment, toxicity, and a year follow-up: Case report.
Antony F; Raphael JC; Varghese MK; Gopu P
Indian J Cancer; 2021; 58(3):434-436. PubMed ID: 34380851
[TBL] [Abstract][Full Text] [Related]
39. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
[TBL] [Abstract][Full Text] [Related]
40. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
